Keyphrases
Population-based
100%
Selective Serotonin Reuptake Inhibitors
100%
Osteoporosis
100%
Fracture Risk
100%
Incident Fractures
100%
Antidepressant Use
100%
Serotonin-noradrenaline Reuptake Inhibitor
47%
Fragility Fracture
35%
Hazard Ratio
11%
Confidence Interval
11%
Bone Mineral Density
11%
Multiple Risk Factors
11%
Adjusted Hazard Ratio
5%
Potential Confounders
5%
High Prevalence
5%
Increasing Risk
5%
Clinical Impact
5%
Administrative Data
5%
Time-to-event
5%
Term Analysis
5%
Selected Populations
5%
Lumbar
5%
Charlson Score
5%
Previous Falls
5%
Event Methodology
5%
Community-based Cohort
5%
Medicine and Dentistry
Selective Serotonin Reuptake Inhibitor
100%
Antidepressant
100%
Osteoporosis
100%
Serotonin-Norepinephrine Reuptake Inhibitor
88%
Fragility Fracture
66%
Hazard Ratio
33%
Bone Density
22%
Prevalence
11%
Hip
11%
Pharmacology, Toxicology and Pharmaceutical Science
Selective Serotonin Reuptake Inhibitor
100%
Antidepressant
100%
Serotonin-Norepinephrine Reuptake Inhibitor
88%
Fragility Fracture
66%
Prevalence
11%
Neuroscience
Selective Serotonin Reuptake Inhibitor
100%
Antidepressant
100%
Serotonin-Norepinephrine Reuptake Inhibitor
88%
Biochemistry, Genetics and Molecular Biology
Selective Serotonin Reuptake Inhibitor
100%
Serotonin-Norepinephrine Reuptake Inhibitor
88%
Bone Density
22%
Prevalence
11%